250 related articles for article (PubMed ID: 25951608)
1. Integrated analysis of transcriptome in cancer patient-derived xenografts.
Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J
Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156
[TBL] [Abstract][Full Text] [Related]
3. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
[TBL] [Abstract][Full Text] [Related]
4. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer.
Chen Z; Huang W; Tian T; Zang W; Wang J; Liu Z; Li Z; Lai Y; Jiang Z; Gao J; Shen L
J Hematol Oncol; 2018 Feb; 11(1):20. PubMed ID: 29433585
[TBL] [Abstract][Full Text] [Related]
5. Novartis Compiles Mouse Avatar "Encyclopedia".
Poh A
Cancer Discov; 2016 Jan; 6(1):5-6. PubMed ID: 26621761
[TBL] [Abstract][Full Text] [Related]
6. Prioritizing therapeutic targets using patient-derived xenograft models.
Lodhia KA; Hadley AM; Haluska P; Scott CL
Biochim Biophys Acta; 2015 Apr; 1855(2):223-34. PubMed ID: 25783201
[TBL] [Abstract][Full Text] [Related]
7. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.
Wang Y; Cui J; Wang L
Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729
[TBL] [Abstract][Full Text] [Related]
10. A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells.
Puig I; Chicote I; Tenbaum SP; Arqués O; Herance JR; Gispert JD; Jimenez J; Landolfi S; Caci K; Allende H; Mendizabal L; Moreno D; Charco R; Espín E; Prat A; Elez ME; Argilés G; Vivancos A; Tabernero J; Rojas S; Palmer HG
Clin Cancer Res; 2013 Dec; 19(24):6787-801. PubMed ID: 24170545
[TBL] [Abstract][Full Text] [Related]
11. Applications of patient-derived tumor xenograft models and tumor organoids.
Yoshida GJ
J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
[TBL] [Abstract][Full Text] [Related]
12. Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.
Damelin M; Bankovich A; Park A; Aguilar J; Anderson W; Santaguida M; Aujay M; Fong S; Khandke K; Pulito V; Ernstoff E; Escarpe P; Bernstein J; Pysz M; Zhong W; Upeslacis E; Lucas J; Lucas J; Nichols T; Loving K; Foord O; Hampl J; Stull R; Barletta F; Falahatpisheh H; Sapra P; Gerber HP; Dylla SJ
Clin Cancer Res; 2015 Sep; 21(18):4165-73. PubMed ID: 26015513
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors.
Koga Y; Ochiai A
Cells; 2019 May; 8(5):. PubMed ID: 31064068
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.
Oyama R; Takahashi M; Kito F; Sakumoto M; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Jun; 54(6):458-467. PubMed ID: 29845452
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived cell models as preclinical tools for genome-directed targeted therapy.
Lee JY; Kim SY; Park C; Kim NK; Jang J; Park K; Yi JH; Hong M; Ahn T; Rath O; Schueler J; Kim ST; Do IG; Lee S; Park SH; Ji YI; Kim D; Park JO; Park YS; Kang WK; Kim KM; Park WY; Lim HY; Lee J
Oncotarget; 2015 Sep; 6(28):25619-30. PubMed ID: 26296973
[TBL] [Abstract][Full Text] [Related]
16. Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts.
Liu Y; Chanana P; Davila JI; Hou X; Zanfagnin V; McGehee CD; Goode EL; Polley EC; Haluska P; Weroha SJ; Wang C
Sci Rep; 2019 Apr; 9(1):6314. PubMed ID: 31004097
[TBL] [Abstract][Full Text] [Related]
17. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
Jung J; Seol HS; Chang S
Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
[TBL] [Abstract][Full Text] [Related]
18. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.
Bieniasz M; Radhakrishnan P; Faham N; De La O JP; Welm AL
Clin Cancer Res; 2015 Dec; 21(24):5588-600. PubMed ID: 26289070
[TBL] [Abstract][Full Text] [Related]
20. Molecular and clinical implementations of ovarian cancer mouse avatar models.
Zayed AA; Mandrekar SJ; Haluska P
Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
